BM
VYNT

Bridger Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bridger Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-350
Closed -$149K – 45
2016
Q1 		$149K Hold
350
– – 0.01% 40
2015
Q4 		$173K Buy
+350
New +$253K 0.01% 38

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Bridger Management's VYNT Position: Q2 2016 in Review

Bridger Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2016, closing a stake of 350 shares — an estimated $149K sold.

Bridger Management first reported a position in VYNT in Q4 2015 and held it in 2 quarters. The position peaked at $173K in Q4 2015. 33 funds tracked by Wall St. Rank hold VYNT as of Q2 2016.

  • Bridger Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Bridger Management sold 350 Vyant Bio, Inc. Common Stock shares in Q2 2016, an estimated $149K.
  • Bridger Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Bridger Management's Vyant Bio, Inc. Common Stock position peaked at $173K in Q4 2015.
  • 33 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2016.

Based on Bridger Management's 13F filing for Q2 2016, filed 15 Aug 2016.